Russia gets hundreds of orders for MC-21 new medium-haul airlinerBusiness & Economy May 25, 13:27
Russia, Philippines ready to sign documents on cooperation in various spheres — LavrovRussian Politics & Diplomacy May 25, 13:23
NATO secretary general says 2011 bombardment of Libya aimed at protecting civiliansWorld May 25, 13:06
Press review: Kiev’s Russian rail cut and Montenegrin opposition’s Russian Crimea stancePress Review May 25, 13:00
Stoltenberg says Russia needs to stop supporting Donbass to improve relations with NATOWorld May 25, 12:41
Russian rotocraft maker expects to sign deal with Defense Ministry on Mi-38 deliveriesMilitary & Defense May 25, 12:31
Death toll from fires in Russia’s Krasnoyarsk region rises to threeWorld May 25, 12:18
Iran expects supplies from Russia within oil-for-food dealBusiness & Economy May 25, 12:16
NATO chief underlines importance of full implementation of Minsk agreementsWorld May 25, 12:07
MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.
"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.
Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.
"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.